ask="100.00"
ask_size="600"
average_daily_volume="304303"
bid="20.15"
bid_size="100"
book_value="3.79"
change="-0.62"
change_from_200_day_moving_average="0.91"
change_from_50_day_moving_average="-2.76"
change_from_52_week_high="-6.55"
change_From_52_week_low="11.13"
change_in_percent="-2.40%"
close="25.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="14358000"
high="25.98"
high_52_weeks="31.80"
last_trade_date="2/6/2017"
last_trade_price="25.25"
last_trade_size="2767"
last_trade_time="4:00pm"
low="24.83"
low_52_weeks="14.12"
market_capitalization="541.16M"
moving_average_200_day="24.34"
moving_average_50_day="28.01"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="25.82"
pe_ratio="N/A"
peg_ratio="-0.18"
percent_change_from_200_day_moving_average="+3.75%"
percent_change_from_50_day_moving_average="-9.85%"
percent_change_from_52_week_high="-20.60%"
percent_change_from_52_week_low="+78.82%"
previous_close="25.87"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.83"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.03"
stock_exchange="NMS"
symbol="ACRS"
volume="260580"
weeks_range_52="14.12 - 31.80"
